Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland
Villano S, Vlahov D, Nelson K, Lyles C, Cohn S, Thomas D. Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland. Journal Of Clinical Microbiology 1997, 35: 3274-3277. PMID: 9399533, PMCID: PMC230161, DOI: 10.1128/jcm.35.12.3274-3277.1997.Peer-Reviewed Original ResearchConceptsInjection drug usersHCV infectionRisk factorsDrug usersDrug useDrug paraphernaliaHepatitis C virus infectionC virus infectionAnnual incidence rateActive drug useHigh-risk sexual practicesSharing of needlesHCV seroconversionHepatitis CAntibody testingOverall incidenceIncidence rateVirus infectionSerum samplesInfectionIncidenceHCVSexual practicesFrequent useParticipantsSeroreactivity to hepatitis E virus in areas where the disease is not endemic
Thomas D, Yarbough P, Vlahov D, Tsarev S, Nelson K, Saah A, Purcell R. Seroreactivity to hepatitis E virus in areas where the disease is not endemic. Journal Of Clinical Microbiology 1997, 35: 1244-1247. PMID: 9114415, PMCID: PMC232737, DOI: 10.1128/jcm.35.5.1244-1247.1997.Peer-Reviewed Original ResearchConceptsInjection drug usersHistory of hepatitisVirus antibodiesBlood donorsHigh-risk drug-using practicesHomosexual menHepatitis E virus antibodiesHepatitis E diseaseC virus antibodyHepatitis C antibodyHigh-risk groupHigh-risk populationHigh-risk sexual practicesDrug use practicesHepatitis AE virusC antibodySubclinical infectionB antibodiesE diseaseDrug usersEnzyme immunoassaySerum samplesHomosexual malesInfection